Patents by Inventor Oded RECHAVI

Oded RECHAVI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS)
    Publication number: 20250057892
    Abstract: Provided are nucleic acid constructs, Toxoplasma comprising same, pharmaceutical compositions comprising same and methods using same for delivering a protein-of-interest to a tissue-of-interest of a subject, such as the CNS and further treating a pathology which is treatable by administration of a therapeutic polypeptide in a central nervous system of the subject.
    Type: Application
    Filed: August 26, 2024
    Publication date: February 20, 2025
    Applicants: Ramot at Tel-Aviv University Ltd., The University Court of the University of Glasgow
    Inventors: Oded RECHAVI, Shahar BRACHA, Lilach SHEINER
  • Engineered parasites for delivering protein to the central nervous system (CNS)
    Patent number: 12070476
    Abstract: Provided are nucleic acid constructs, Toxoplasma comprising same, pharmaceutical compositions comprising same and methods using same for delivering a protein-of-interest to a tissue-of-interest of a subject, such as the CNS and further treating a pathology which is treatable by administration of a therapeutic polypeptide in a central nervous system of the subject.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: August 27, 2024
    Assignees: Ramot at Tel-Aviv University Ltd., The University Court of the University of Glasgow
    Inventors: Oded Rechavi, Shahar Bracha, Lilach Sheiner
  • ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS)
    Publication number: 20220160790
    Abstract: Provided are nucleic acid constructs, Toxoplasma comprising same, pharmaceutical compositions comprising same and methods using same for delivering a protein-of-interest to a tissue-of-interest of a subject, such as the CNS and further treating a pathology which is treatable by administration of a therapeutic polypeptide in a central nervous system of the subject.
    Type: Application
    Filed: January 26, 2022
    Publication date: May 26, 2022
    Applicants: Ramot at Tel-Aviv University Ltd., The University Court of the University of Glasgow
    Inventors: Oded RECHAVI, Shahar BRACHA, Lilach SHEINER
  • Engineered parasites for delivering protein to the central nervous system (CNS)
    Patent number: 11260081
    Abstract: Provided are nucleic acid constructs, Toxoplasma comprising same, pharmaceutical compositions comprising same and methods using same for delivering a protein-of-interest to a tissue-of-interest of a subject, such as the CNS and further treating a pathology which is treatable by administration of a therapeutic polypeptide in a central nervous system of the subject.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: March 1, 2022
    Assignees: Ramot at Tel-Aviv University Ltd., The Universitv Court of the University of Glasgow
    Inventors: Oded Rechavi, Shahar Bracha, Lilach Sheiner
  • ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS)
    Publication number: 20200121731
    Abstract: Provided are nucleic acid constructs, Toxoplasma comprising same, pharmaceutical compositions comprising same and methods using same for delivering a protein-of-interest to a tissue-of-interest of a subject, such as the CNS and further treating a pathology which is treatable by administration of a therapeutic polypeptide in a central nervous system of the subject.
    Type: Application
    Filed: June 29, 2017
    Publication date: April 23, 2020
    Applicants: Ramat at Tel-Aviv University Ltd., The University Court of the University of Glasgow
    Inventors: Oded RECHAVI, Shahar BRACHA, Lilach SHEINER